Last $15.93 USD
Change Today +0.95 / 6.34%
Volume 2.4M
NKTR On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 5:20 PM 11/25/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Allen J. Sedman M.D., Ph.D.

Member of Proprietary Products Strategic Advisory Board, Nektar Therapeutics
AgeTotal Calculated CompensationThis person is connected to 28 board members in 1 different organizations across 3 different industries.

See Board Relationships
----

Background*

Dr. Allen J. Sedman, M.D., Ph.D., served as Vice President of Clinical Pharmacology of Parke Davis. Dr. Sedman oversaw the exploratory clinical development of drugs such as Neurontin(R), Lipitor(R) and Accupril(R). Dr. Sedman served as Vice President of Clinical Sciences and Head of Pfizer Global Research and Development of Ann Arbor, Michigan. He has expertise in Clinical drug development in General and Special Expertise in clinical pharmacology. His research interests ...

Read Full Background

Corporate Headquarters*

455 Mission Bay Boulevard South
San Francisco, California 94158

United States

Phone: 415-482-5300
Fax: 415-339-5300

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

MS
University of Michigan
PhD
University of Michigan
BS 1969
University of Michigan
BSE 1969
University of Michigan
MD 1978
Washington University, St. Louis
Unknown/Other Education
University of Colorado–Boulder

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NKTR:US $15.93 USD +0.95

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Michael W. Aguiar Chief Executive Officer, President and Director
Theravance Inc.
$515.4K
Peter M. Hecht Ph.D. Co-Founder, Chief Executive Officer and Director
Ironwood Pharmaceuticals, Inc.
$100.0K
James A. Schoeneck Chief Executive Officer, President and Director
DepoMed Inc.
$590.6K
George Frederick Wilkinson Chief Executive Officer, President and Director
Impax Laboratories Inc.
--
Daniel J. Abdun-Nabi Chief Executive Officer, President, Director and Member of Strategic Operations Committee
Emergent BioSolutions, Inc.
$1.0M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NEKTAR THERAPEUTICS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.